Login / Signup

Evaluation of laboratory assays for anti-platelet factor 4 antibodies after ChAdOx1 nCOV-19 vaccination.

Sean PlattonAndrew BartlettPeter MacCallumMike MakrisVickie McDonaldDeepak SinghMarie ScullySue Pavord
Published in: Journal of thrombosis and haemostasis : JTH (2021)
We demonstrated that the HemosIL AcuStar HIT-IgG, HemosIL HIT-Ab, Diamed PaGIA gel, and STic Expert assays have poor sensitivity for VITT in comparison to ELISA. Where these assays are used for heparin-induced thrombocytopenia (HIT) diagnosis, laboratories should ensure that requests for suspected VITT are clearly identified so that an ELISA is performed. No superiority of IgG-ELISAs over polyspecific ELISAs in sensitivity to VITT could be demonstrated. No single ELISA method detected all possible/probable VITT cases; if a single ELISA test is negative, a second ELISA or a platelet activation assay should be considered where there is strong clinical suspicion.
Keyphrases
  • high throughput
  • monoclonal antibody
  • venous thromboembolism
  • high glucose
  • diabetic rats
  • growth factor
  • oxidative stress
  • clinical practice
  • single cell
  • endothelial cells
  • wound healing